Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

We performed a retrospective analysis of the outcome of 197 consecutive unrelated donor transplant recipients who received GVHD prophylaxis either TM regimen (tacrolimus and mycophenolate) (121 patients) or TM/ATG-G regimen (TM with low-dose antithymocyte globulin (ATG) of 4.5 mg/kg, ATG-G, Genzyme)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bone Marrow Transplant
Glavni autori: Ratanatharathorn, V, Deol, A, Ayash, L, Cronin, S, Bhutani, D, Lum, LG, Abidi, M, Ventimiglia, M, Mellert, K, Uberti, JP
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286438/
https://ncbi.nlm.nih.gov/pubmed/25285804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2014.203
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items